IncobotulinumtoxinA (400 Units)

DRUG2 trials

Sponsors

Merz Pharmaceuticals GmbH

Conditions

Post-stroke Spasticity of the Lower LimbPost-stroke Spasticity of the Upper Limb

Phase 3

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke

CompletedNCT01392300

Merz Pharmaceuticals GmbHPost-stroke Spasticity of the Upper Limb

Start: 2011-09-30End: 2014-02-28Updated: 2017-01-16

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke

CompletedNCT01464307

Merz Pharmaceuticals GmbHPost-stroke Spasticity of the Lower Limb

Start: 2011-12-31End: 2015-05-31Updated: 2016-11-07

Related Papers

Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.

2021-01-052 citations

IncobotulinumtoxinA Treatment in Upper‐Limb Poststroke Spasticity in the Open‐Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life

PM&R2019-10-247 citations

IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.

2018-11-2716 citations

Topline results from a randomized, placebo-controlled, Phase III study investigating the safety and efficacy of incobotulinumtoxinA in treating post-stroke spasticity of the upper limb (S28.002)

Neurology2015-04-06